Retour
Prix Scinai Immunotherapeutics Ltd (SCNI)
Graphique du cours de l'action SCNI
SCNI Dividendes
Scinai Immunotherapeutics Ltd
$0.86
-4.86%
$-0.04
À la fermeture : Jan 16, 16:00:00 GMT-5
$0.87
0.57%
$0
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$0.9092
Prix d'ouverture
$0.954
Plage de la journée
$0.865 - $0.963
Plage de 52 semaines
$0.613 - $6.18
Volume
11.3K
Volume moyen
52.4K
BPA (TTM)
0.00
Rendement en dividend
--
Capitalisation boursière
$2.7M
Qu’est-ce que SCNI ?
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
